Publication | Closed Access

Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity — I. Disease modifying action on adjuvant arthritis of the rat

InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryAutoimmune DiseaseMedicineAdjuvant ArthritisImmunologyOsteoarthritisInflammatory Rheumatic DiseaseNovel Isoxazol DerivativePharmacologyInflammatory DiseaseInflammatory ArthritisRheumatoid ArthritisHwa 486